Secura Bio
NV - Las VegasBiotechnology
Focus: Secura Bio is a public oncology-focused biotech company headquartered in Las Vegas that acquires and commercializes cancer therapies globally. With only 3 active job openings and 100% revenue concentration in COPIKTRA, the company operates as a lean, product-focused commercial entity.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3
Should You Work at Secura Bio?
AI assessmentSecura Bio suits early-career professionals seeking focused oncology commercial experience in a stable public company, but limited growth headroom and pipeline depth make it a transitional rather than long-term career anchor.
Why Work Here
- Focused oncology portfolio in lymphoid malignancies with established FDA-approved therapies generating measurable Part D revenue ($21M for COPIKTRA)
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
10 total
LOE Risk
1 in 5yr
FARYDAK
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$21M (Part D)Stable
Peak
Help build intelligence for Secura Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.